Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Sep;190(5):684-695.
doi: 10.1111/bjh.16704. Epub 2020 May 10.

Guidelines on the use of prophylactic factor replacement for children and adults with Haemophilia A and B

Rachel Rayment  1 , Elizabeth Chalmers  2 , Katherine Forsyth  3 , Richard Gooding  4 , Anne M Kelly  5 , Susan Shapiro  6 , Kate Talks  7 , Oliver Tunstall  8 , Tina Biss  7 ; British Society for Haematology
Affiliations
Review

Guidelines on the use of prophylactic factor replacement for children and adults with Haemophilia A and B

Rachel Rayment et al. Br J Haematol. 2020 Sep.
No abstract available

PubMed Disclaimer

Comment in

References

    1. Richards M, Williams M, Chalmers E, Liesner R, Collins P, Vidler V, et al. A United Kingdom Haemophilia Centre Doctors' Organization guideline approved by the British Committee for Standards in Haematology: guideline on the use of prophylactic factor VIII concentrate in children and adults with severe haemophilia A. Br J Haematol. 2010;149:498-507.
    1. Blanchette VS, Key NS, Ljung LR, Manco-Johnson MJ, van den Berg HM, Srivastava A. Definitions in hemophilia: communication from the SSC of the ISTH. J Thromb Haemost. 2014;12:1935-9.
    1. Manco-Johnson MJ, Abshire TC, Shapiro AD, Riske B, Hacker MR, Kilcoyne R, et al. Prophylaxis versus episodic treatment to prevent joint disease in boys with severe hemophilia. N Engl J Med. 2007;357:535-44.
    1. Gringeri A, Lundin B, Von Mackensen S, Mantovani L, Mannucci PM; the ESPRIT Study. A randomized clinical trial of prophylaxis in children with hemophilia A (the ESPRIT Study). J Thromb Haemost. 2011;9:700-10.
    1. Manco-Johnson M, Kempton C, Reding M, Lissitchkov T, Goranov S, Gercheva L, et al. Randomized, controlled, parallel-group trial of routine prophylaxis vs. on-demand treatment with sucrose-formulated recombinant factor VIII in adults with severe hemophilia A (SPINART). J Thromb Haemost. 2013;11:1119-27.

LinkOut - more resources